UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 25, 2007

BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification)
     
2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices, including Zip Code)
     
Registrant’s telephone number, including area code: (801) 972-5555
     
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 7.01    Regulation FD Disclosure.
 
BSD Medical Corporation issued a press release on July 25, 2007. A copy of the press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01    Financial Statements and Exhibits.
 
(d)
Exhibits
 
99.1
Press Release of BSD Medical Corporation dated July 25, 2007



 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: July 25, 2007    
 
 		  
 		  
 
  By:   /s/ Hyrum A. Mead
 
  President
 
 
 
 

EXHIBIT INDEX
 
Exhibit No. Description
   
99.1
Press Release of BSD Medical Corporation dated July 25, 2007